688177 百奥泰
午间休市 12-24 11:29:37
资讯
新帖
简况
百奥泰12月23日遭主力抛售644万元 环比增加1363.64%
市场透视 · 12-23 15:20
百奥泰12月23日遭主力抛售644万元 环比增加1363.64%
百奥泰12月18日获主力加仓368万元 环比增加318.18%
市场透视 · 12-18
百奥泰12月18日获主力加仓368万元 环比增加318.18%
百奥泰:与Stein就BAT2306(司库奇尤单抗)注射液签署授权许可及生产、供货和商业化协议
美港电讯 · 12-16
百奥泰:与Stein就BAT2306(司库奇尤单抗)注射液签署授权许可及生产、供货和商业化协议
百奥泰(688177.SH)与Stein就司库奇尤单抗签署授权许可及生产、供货和商业化协议
智通财经 · 12-16
百奥泰(688177.SH)与Stein就司库奇尤单抗签署授权许可及生产、供货和商业化协议
百奥泰最新公告:与SteinCares签署最高800万美元授权许可及生产、供货和商业化协议
证券之星 · 12-16
百奥泰最新公告:与SteinCares签署最高800万美元授权许可及生产、供货和商业化协议
百奥泰12月13日主力资金流入123万元 连续3日加仓
市场透视 · 12-13
百奥泰12月13日主力资金流入123万元 连续3日加仓
百奥泰12月06日主力资金流出355万元 连续3日减仓
市场透视 · 12-06
百奥泰12月06日主力资金流出355万元 连续3日减仓
百奥泰12月02日主力资金流出540万元 连续5日减仓
市场透视 · 12-02
百奥泰12月02日主力资金流出540万元 连续5日减仓
百奥泰大涨 国家医保调整
智选洞察 · 12-02
百奥泰大涨 国家医保调整
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
百奥泰11月27日遭主力抛售442万元 环比增加274.58%
市场透视 · 11-27
百奥泰11月27日遭主力抛售442万元 环比增加274.58%
百奥泰:11月25日召开业绩说明会,投资者参与
证券之星 · 11-25
百奥泰:11月25日召开业绩说明会,投资者参与
百奥泰回应BAT8006授权问题:始终关注和积极推进研发进程
财经网 · 11-25
百奥泰回应BAT8006授权问题:始终关注和积极推进研发进程
百奥泰11月22日主力资金流入975万元 连续3日加仓
市场透视 · 11-22
百奥泰11月22日主力资金流入975万元 连续3日加仓
百奥泰:公司2024年1-9月实现营业收入5.81亿元,同比增长26.11%
证券之星 · 11-21
百奥泰:公司2024年1-9月实现营业收入5.81亿元,同比增长26.11%
百奥泰:公司贝伐珠单抗在欧盟和美国尚未开始销售
每日经济新闻 · 11-21
百奥泰:公司贝伐珠单抗在欧盟和美国尚未开始销售
百奥泰11月14日主力资金流出198万元 连续5日减仓
市场透视 · 11-14
百奥泰11月14日主力资金流出198万元 连续5日减仓
百奥泰最新公告:收到吉瑞医药1000万美元首付款及里程碑付款
证券之星 · 11-13
百奥泰最新公告:收到吉瑞医药1000万美元首付款及里程碑付款
百奥泰:收到由吉瑞医药一次性支付的1000万美元
格隆汇 · 11-13
百奥泰:收到由吉瑞医药一次性支付的1000万美元
百奥泰:业绩说明会定于11月25日举行
每日经济新闻 · 11-12
百奥泰:业绩说明会定于11月25日举行
加载更多
公司概况
公司名称:
百奥泰生物制药股份有限公司
所属行业:
医药制造业
上市日期:
2020-02-21
主营业务:
百奥泰生物制药股份有限公司的主营业务是药物的研发、生产和销售。公司的主要产品是创新药和生物类似药,用于治疗肿瘤、自身免疫性疾病、心血管疾病以及其它危及人类生命或健康的重大疾病。
发行价格:
32.76
{"stockData":{"symbol":"688177","market":"SH","secType":"STK","nameCN":"百奥泰","latestPrice":20,"timestamp":1735010977000,"preClose":20.05,"halted":0,"volume":716855,"delay":0,"floatShares":413999999,"shares":413999999,"eps":-0.9121,"marketStatus":"午间休市","marketStatusCode":3,"change":-0.05,"latestTime":"12-24 11:29:37","open":20.12,"high":20.2,"low":19.93,"amount":14348800,"amplitude":0.0135,"askPrice":19.99,"askSize":2,"bidPrice":19.96,"bidSize":26,"shortable":0,"etf":0,"ttmEps":-0.9121,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735016400000},"adr":0,"adjPreClose":20.05,"symbolType":"stock_kcb","openAndCloseTimeList":[[1735003800000,1735011000000],[1735016400000,1735023600000]],"highLimit":22.06,"lowLimit":18.05,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":414080000,"pbRate":9.8,"roa":"--","roe":"--","epsLYR":-0.95,"committee":0.680129,"marketValue":8282000000,"floatMarketCap":8282000000,"peRate":-21.92742,"changeRate":-0.0025,"turnoverRate":0.0017,"status":1},"requestUrl":"/m/hq/s/688177","defaultTab":"news","newsList":[{"id":"2493780935","title":"百奥泰12月23日遭主力抛售644万元 环比增加1363.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493780935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493780935?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:20","pubTimestamp":1734938438,"startTime":"0","endTime":"0","summary":"12月23日, 百奥泰股价跌3.42%,报收20.05元,成交金额4656万元,换手率0.55%,振幅4.00%,量比1.47。百奥泰今日主力资金净流出644万元,连续3日净流出,上一交易日主力净流出44万元,今日环比增加1363.64%。|12月23日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|卓翼科技|10.67%|#|小方制药|7.78%|#|威领股份|4.64%|#|蒙娜丽莎|4.32%|#|C博科测试|3.47%|#|爱婴室|3.26%|#|南凌科技|2.82%|#|威奥股份|2.71%|#|晶华微|2.61%|#|潍柴重机|2.53%|百奥泰所在的生物制品行业,今日主力净流出3.65亿元,行业排名31/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223154043a20414ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223154043a20414ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2492908257","title":"百奥泰12月18日获主力加仓368万元 环比增加318.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492908257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492908257?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:19","pubTimestamp":1734506389,"startTime":"0","endTime":"0","summary":"12月18日, 百奥泰股价跌0.57%,报收20.84元,成交金额2546万元,换手率0.29%,振幅1.67%,量比0.61。百奥泰今日主力资金净流入368万元,上一交易日主力净流入88万元,今日环比增加318.18%。|12月18日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|海能达|7.07%|#|爱朋医疗|4.89%|#|通达动力|4.37%|#|星宸科技|4.27%|#|诚益通|4.20%|#|博士眼镜|4.02%|#|世嘉科技|3.99%|#|博瑞传播|3.98%|#|瀛通通讯|3.77%|#|星光股份|3.77%|百奥泰所在的生物制品行业,今日主力净流出3967万元,行业排名30/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218153901a1f7e8f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218153901a1f7e8f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2491657405","title":"百奥泰:与Stein就BAT2306(司库奇尤单抗)注射液签署授权许可及生产、供货和商业化协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2491657405","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491657405?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:36","pubTimestamp":1734341764,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2491574946","title":"百奥泰(688177.SH)与Stein就司库奇尤单抗签署授权许可及生产、供货和商业化协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2491574946","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491574946?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:34","pubTimestamp":1734341669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥泰 发布公告,公百奥泰与Stein于北京时间2024年12月16日就BAT2306注射液签署授权许可及生产、供货和商业化协议。根据协议约定,百奥泰将自主研发且具有自主知识产权的BAT2306注射液在巴西以及其余拉丁美洲地区市场的独占的产品商业化权益有偿许可给Stein。在协议生效后,Stein将向百奥泰一次性支付120万美元首付款。百奥泰在达到相应的里程碑事件后,Stein将向百奥泰支付累计不超过680万美元的里程碑款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2491657189","title":"百奥泰最新公告:与SteinCares签署最高800万美元授权许可及生产、供货和商业化协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2491657189","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491657189?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:30","pubTimestamp":1734341454,"startTime":"0","endTime":"0","summary":"百奥泰公告,与SteinCares签署授权许可及生产、供货和商业化协议,将BAT2306(司库奇尤单抗)注射液在巴西及其余拉丁美洲地区的独占产品商业化权益有偿许可给Stein。交易金额为首付款及里程碑款总金额最高至800万美元,包括120万美元首付款、累计不超过680万美元里程碑付款,以及净销售额的两位数百分比作为收入分成。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600024244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2491018473","title":"百奥泰12月13日主力资金流入123万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491018473","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491018473?lang=zh_cn&edition=full","pubTime":"2024-12-13 15:21","pubTimestamp":1734074500,"startTime":"0","endTime":"0","summary":"12月13日, 百奥泰股价跌2.52%,报收21.64元,成交金额5319万元,换手率0.59%,振幅3.11%,量比1.03。百奥泰今日主力资金净流入123万元,连续3日净流入,上一交易日主力净流入335万元,今日环比减少63.28%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为33.33%,平均涨幅为4.60%。该股近5个交易日下跌2.61%,主力资金累计净流入181万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出646万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213155001a1eb5873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213155001a1eb5873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2489286474","title":"百奥泰12月06日主力资金流出355万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2489286474","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489286474?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:21","pubTimestamp":1733469676,"startTime":"0","endTime":"0","summary":"12月06日, 百奥泰股价涨1.14%,报收22.22元,成交金额4906万元,换手率0.54%,振幅3.64%,量比0.77。百奥泰今日主力资金净流出355万元,连续3日净流出,上一交易日主力净流出255万元,今日环比增加39.22%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为60.00%,平均跌幅为3.03%。该股近5个交易日上涨2.63%,主力资金累计净流出1093万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出2067万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206154200ab61f348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206154200ab61f348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2488628214","title":"百奥泰12月02日主力资金流出540万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2488628214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488628214?lang=zh_cn&edition=full","pubTime":"2024-12-02 15:21","pubTimestamp":1733124062,"startTime":"0","endTime":"0","summary":"12月02日, 百奥泰股价涨4.30%,报收22.58元,成交金额9626万元,换手率1.04%,振幅6.10%,量比1.87。百奥泰今日主力资金净流出540万元,连续5日净流出,上一交易日主力净流出659万元,今日环比减少18.06%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为57.14%,平均跌幅为1.35%。该股近5个交易日上涨5.56%,主力资金累计净流出2424万元;近20日主力资金累计净流出2507万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202154106a265a453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202154106a265a453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2488612562","title":"百奥泰大涨 国家医保调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2488612562","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488612562?lang=zh_cn&edition=full","pubTime":"2024-12-02 10:28","pubTimestamp":1733106530,"startTime":"0","endTime":"0","summary":"12月02日,百奥泰股价大幅上涨,截至10点28分,百奥泰上涨5.13%,报22.76元/股,成交5218万元,换手率0.57%,振幅5.36%。消息解读近日,国家医保局公布了2024年国家医保药品目录调整结果,新增91种药品,调出43种药品。此外,国家医保局正在谋划推进医保数据赋能商业保险公司、医保基金与商业保险同步结算等支持政策。资金动向截止发稿,百奥泰获得主力净流出239万元,其中超大单流出183万元,大单流出54万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202103001a2650048&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202103001a2650048&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0096","688046","688373","600566","603233","688189","688488","159938","BK0070","600572","688321","600511","688271","688137","600771","600196","603367","600521","603707","600422","688212","600851","688578","688266","600721","BK0185","603439","688315","603567","600211","688235","688221","600535","688091","688690","600085","688085","603259","600080","688443","600420","688176","600055","600329","688192","600285","688575","688105","603858","603392","603896","600351","600161","688617","688356","688389","688161","688298","600763","688351","603658","688117","600739","600529","688656","688336","688520","603309","688076","600252","688193","600436","600062","688073","603456","688331","688050","688301","600276","600998","600867","688382","688198","688114","688067","603590","688139","688506","603882","600380","688670","603108","688687","688222","688767","BK0188","600056","688177","603301","603127","BK0012","600488","605199","601607","688029","688276","688581","600976","603538","688166","600129","600200","688247","688180","688566","688163","603939","605177","603087","BK0239","600332","688202","688278","688062","688626","BK0028","688428","600079"],"gpt_icon":0},{"id":"2486420819","title":"百奥泰11月27日遭主力抛售442万元 环比增加274.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486420819","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486420819?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:21","pubTimestamp":1732692111,"startTime":"0","endTime":"0","summary":"11月27日, 百奥泰股价涨1.92%,报收21.76元,成交金额4090万元,换手率0.46%,振幅3.84%,量比0.73。百奥泰今日主力资金净流出442万元,上一交易日主力净流出118万元,今日环比增加274.58%。|11月27日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|中仑新材|8.78%|#|恒信东方|7.99%|#|岭南股份|7.89%|#|康冠科技|6.15%|#|华如科技|6.12%|#|天地在线|5.89%|#|汇金科技|5.75%|#|汤姆猫|5.14%|#|方直科技|5.05%|#|跨境通|4.94%|百奥泰所在的生物制品行业,今日主力净流出1.50亿元,行业排名8/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153950a2592431&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153950a2592431&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2486773706","title":"百奥泰:11月25日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2486773706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486773706?lang=zh_cn&edition=full","pubTime":"2024-11-25 18:04","pubTimestamp":1732529064,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月25日百奥泰发布公告称公司于2024年11月25日召开业绩说明会。公司严格按照相关法律法规及股东提交的减持计划和进展进行信息披露,不存在操纵股价的行为。BAT5906 预计于 2025 年上半年完成 3期临床,期望能在 2025 年内递交上市申请。公司已及时披露了 BT1706 和BT1806 的欧美授权协议及首付款情况,目前协议正常履行中,协议具体条款受到商业保密协议的约束,若有进一步进展,公司会及时进行披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500025022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2486261487","title":"百奥泰回应BAT8006授权问题:始终关注和积极推进研发进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2486261487","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486261487?lang=zh_cn&edition=full","pubTime":"2024-11-25 11:59","pubTimestamp":1732507188,"startTime":"0","endTime":"0","summary":"11月25日,百奥泰举办2024年第三季度业绩说明会。公司已及时披露了BAT1706和BAT1806的欧美授权协议及首付款情况,目前协议正常履行中,协议具体条款受到商业保密协议的约束,若有进一步进展,公司会及时进行披露。还有投资者质疑,BAT8006授权出去是一个比较好的选择,是不是因为产品数据和应用潜力不够好,所以授权不出去?对此,管理层回应,关于产品是否授权,每家公司都有自己的策略和规划,不能一概而论,公司始终关注和积极推进BAT8006的研发进程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125120008abdcc52e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125120008abdcc52e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2485287602","title":"百奥泰11月22日主力资金流入975万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2485287602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485287602?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:19","pubTimestamp":1732259967,"startTime":"0","endTime":"0","summary":"11月22日, 百奥泰股价跌4.13%,报收21.12元,成交金额6019万元,换手率0.68%,振幅4.45%,量比0.91。百奥泰今日主力资金净流入975万元,连续3日净流入,上一交易日主力净流入498万元,今日环比增加95.78%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为33.33%,平均涨幅为5.47%。该股近5个交易日下跌4.69%,主力资金累计净流入1959万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2144万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153050a24d48e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153050a24d48e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2485686934","title":"百奥泰:公司2024年1-9月实现营业收入5.81亿元,同比增长26.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485686934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485686934?lang=zh_cn&edition=full","pubTime":"2024-11-21 18:00","pubTimestamp":1732183236,"startTime":"0","endTime":"0","summary":"证券之星消息,百奥泰11月21日在投资者关系平台上答复投资者关心的问题。投资者:公司1季度营收只有1.6亿多,请问公司今年的营收目标是多少?公司2024年1-9月实现营业收入5.81亿元,同比增长26.11%。公司根据会计准则进行收入确认,Hikma的1,000万里程碑有部分计入收入,营业收入分解信息的具体情况详见公司在法定媒体披露《百奥泰2024年半年度报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100029710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688177"],"gpt_icon":0},{"id":"2485045222","title":"百奥泰:公司贝伐珠单抗在欧盟和美国尚未开始销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2485045222","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485045222?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:25","pubTimestamp":1732181114,"startTime":"0","endTime":"0","summary":"象阿达木单抗是全球畅销药,但市占率并不高。在巴西、独联体等国家是否获批上市?百奥泰11月21日在投资者互动平台表示,公司贝伐珠单抗在欧盟和美国尚未开始销售;TOFIDENCE于今年5月开始在美国销售,欧盟上市时间暂未确定,其他海外市场暂未获批上市,公司会积极跟进推动相关进程。公司根据会计准则进行收入确认,Hikma的1,000万里程碑有部分计入收入,营业收入分解信息的具体情况详见公司在法定媒体披露《百奥泰2024年半年度报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121172620abd45032&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121172620abd45032&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2483597841","title":"百奥泰11月14日主力资金流出198万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483597841","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483597841?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:21","pubTimestamp":1731568874,"startTime":"0","endTime":"0","summary":"11月14日, 百奥泰股价跌2.78%,报收23.09元,成交金额5892万元,换手率0.61%,振幅5.64%,量比0.79。百奥泰今日主力资金净流出198万元,连续5日净流出,上一交易日主力净流出208万元,今日环比减少4.81%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为57.14%,平均跌幅为1.35%。该股近5个交易日下跌4.15%,主力资金累计净流出2106万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1508万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114154655abc02656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114154655abc02656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2483020027","title":"百奥泰最新公告:收到吉瑞医药1000万美元首付款及里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2483020027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483020027?lang=zh_cn&edition=full","pubTime":"2024-11-13 16:44","pubTimestamp":1731487492,"startTime":"0","endTime":"0","summary":"百奥泰公告,公司于2024年10月8日与吉瑞医药就BAT2206注射液签署授权许可及生产、供货和商业化协议。根据协议约定,百奥泰于2024年11月13日收到由吉瑞医药一次性支付的1000万美元,其中包括850万美元首付款及150万美元里程碑付款,共计人民币7199.1万元。该笔款项的到账,进一步充盈了公司的现金储备,也为公司后续管线研发和国际化战略的推进提供助力。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300026745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000978.SH","688177"],"gpt_icon":0},{"id":"2483017021","title":"百奥泰:收到由吉瑞医药一次性支付的1000万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483017021","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483017021?lang=zh_cn&edition=full","pubTime":"2024-11-13 16:15","pubTimestamp":1731485719,"startTime":"0","endTime":"0","summary":"首付款及里程碑款总金额最高至1.10亿美元,其中包括850万美元首付款、累计不超过1.015亿美元里程碑付款,以及净销售额的两位数百分比作为收入分成。根据协议约定,百奥泰于2024年11月13日收到由吉瑞医药一次性支付的1,000万美元,其中包括850万美元首付款及150万美元里程碑付款,按照2024年11月13日中国人民银行公布的美元兑人民币中间价7.1991,共计人民币7,199.10万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161519a2332247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161519a2332247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","159938","BK0239"],"gpt_icon":0},{"id":"2482207807","title":"百奥泰:业绩说明会定于11月25日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2482207807","media":"每日经济新闻","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482207807?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:59","pubTimestamp":1731401972,"startTime":"0","endTime":"0","summary":"每经AI快讯,百奥泰 11月12日晚间发布公告称,公司2024年第三季度业绩说明会定于2024年11月25日上午10:00-11:00,以上证路演中心网络互动的形式进行。2023年1至12月份,百奥泰的营业收入构成为:医药制造占比100.0%。百奥泰的董事长、总经理均是LI SHENGFENG(李胜峰),男,65岁,学历背景为博士。截至发稿,百奥泰市值为100亿元。道达号“个股趋势”提醒:1. 近30日内无机构对百奥泰进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112165947abb96b14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112165947abb96b14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-02-21","address":"广东省广州市黄埔区高新技术产业开发区科学城开源大道11号A6栋第五层","stockEarnings":[{"period":"1week","weight":-0.0511},{"period":"1month","weight":-0.0507},{"period":"3month","weight":0.0454},{"period":"6month","weight":-0.0936},{"period":"1year","weight":-0.4955},{"period":"ytd","weight":-0.5138}],"companyName":"百奥泰生物制药股份有限公司","boardCode":"AI0027","perCapita":"50571股","boardName":"医药制造业","registeredCapital":"41408万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":" 百奥泰生物制药股份有限公司的主营业务是药物的研发、生产和销售。公司的主要产品是创新药和生物类似药,用于治疗肿瘤、自身免疫性疾病、心血管疾病以及其它危及人类生命或健康的重大疾病。","serverTime":1735013235310,"listedPrice":32.76,"stockholders":"8188人(较上一季度减少11.98%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥泰(688177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥泰(688177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥泰,688177,百奥泰股票,百奥泰股票老虎,百奥泰股票老虎国际,百奥泰行情,百奥泰股票行情,百奥泰股价,百奥泰股市,百奥泰股票价格,百奥泰股票交易,百奥泰股票购买,百奥泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥泰(688177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥泰(688177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}